𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson’s disease

✍ Scribed by Catherine L. Gallagher; Sterling C. Johnson; Barbara B. Bendlin; Moo K. Chung; James E. Holden; Terrence R. Oakes; Benjamin R. Brooks; Richard A. Konopacki; Selami Dogan; James H. Abbs; Guofan Xu; Robert J. Nickles; Robert W. Pyzalski; Onofre T. DeJesus; W. Douglas Brown

Book ID
107472085
Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
366 KB
Volume
5
Category
Article
ISSN
1931-7557

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rate of 6-[18F]fluorodopa uptake decline
Rate of 6-[18F]fluorodopa uptake decline in striatal subregions in Parkinson's disease
✍ Catherine L. Gallagher; Terrence R. Oakes; Sterling C. Johnson; Moo K. Chung; Ja 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 987 KB

## Abstract ## Background: Rate of decline in 6‐L‐[^18^F]fluorodopa (FDOPA) uptake within the striatum has been reported as showing regional differences in Parkinson's disease (PD). ## Methods: We acquired longitudinal brain FDOPA positron emission tomography (PET) studies in 26 PD subjects and

Striatal subregional 6-[18F]fluoro-L-dop
Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: A two-year follow-up study
✍ Anna Brück; Sargo Aalto; Elina Nurmi; Tero Vahlberg; Jörgen Bergman; Juha O. Rin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

## Abstract Thirty‐one drug‐naive patients with Parkinson's disease (PD) underwent 6‐[^18^F]fluoro‐L‐dopa (F‐dopa) positron emission tomography (PET) scan at the time of the diagnosis (baseline) and 2 years later in order to investigate F‐dopa uptake in striatal and extrastriatal regions during the

Striatal uptake of a novel PET ligand, [
Striatal uptake of a novel PET ligand, [18F]β-CFT, is reduced in early Parkinson's disease
✍ J.O. Rinne; J. Bergman; H. Ruottinen; M. Haaparanta; E. Eronen; V. Oikonen; P. S 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

[18F] beta-CFT is a novel PET ligand for dopamine reuptake sites. In this study, [18F]beta-CFT uptake was studied in nine patients with early Parkinson's disease (PD) without antiparkinsonian medication and in six age-matched controls. The uptake of [18F]beta-CFT was calculated as a (region-cerebell